The Liver Research Institute at the University of Arizona provides state-of-the-art treatments for patients with all forms of liver disease. By participating in clinical trials of new therapies, the institute is able to provide many patients with early access to potentially life-saving treatments before they are available to the general public. Clinical trials are performed in collaboration with the pharmaceutical/device industry as well as the National Institutes of Health.
Areas of research at the institute include:
- Treatment of viral hepatitis B and C
- Treatment of complications of cirrhosis
- Hepatorenal syndrome
- Hepatic encephalopathy
- Non-alcoholic steatohepatitis
- Treatment outcomes
Current Clinical Trials
Clinical trials often involve a research study conducted to evaluate a medical procedure or medical product, such as a drug. Not all University of Arizona studies involve drugs or interventions. Some studies use surveys or evaluate medical records to find new and better ways to help people. Others recruit healthy subjects, or controls, to better evaluate and compare results with those of non-healthy subjects.
Find clinical trials currently recruiting patients in these categories:
How to Participate
Whether you’re a potential candidate to participate as a patient or subject in the study, you would like to participate as a "healthy volunteer" for the control group or you’re a research or clinical professional interested in collaborating with the research team—simply contact the study coordinator listed for each individual clinical research study above.
You can also contact the Liver Research Institute directly at (520) 626-3005 to enquire about other research opportunities.